Skip to main content

1 Result(s)

within Michael E. Autenrieth Remove this filter

and

  1. No Access

    Article

    Treatment of carcinoma in situ of the urinary bladder with an alpha-emitter immunoconjugate targeting the epidermal growth factor receptor: a pilot study

    Patients with carcinoma in situ (CIS) of the bladder refractory to bacillus Calmette-Guérin (BCG) treatment are usually treated with cystectomy. Therefore, new treatment options with preservation of the urinar...

    Michael E. Autenrieth, Christof Seidl… in European Journal of Nuclear Medicine and M… (2018)